Euroapi News and Activities

Presence

Euroapi makes active pharmaceutical ingredients and related solutions for medicines. Its products and services support pharmaceutical companies and healthcare customers that need reliable ingredient supply and development support.

Euroapi products and services overview:

Active ingredients
Contract development
Contract manufacturing
Small molecule APIs
Vitamin B12
Prostaglandins

Revenue: ~$1 billion

Employees: 3,400

Headquarters: Paris, France

Euroapi is owned by Sanofi.

Sanofi is one of the...

Sanofi is a company listed under the stock ticker SAN (FR).

Sanofi has a direct presence in 33 countries.

Sanofi has 46 subsidiaries including Blueprint Medicines, Euroapi and Genzyme Denmark.

They are in:

Acquisition, funding and merger involving Sanofi.

Sanofi has acquired Dynavax Technologies (posted on February 23 2026).
Sanofi has announced the acquisition of Dynavax Technologies (posted on December 29 2025).
Sanofi has announced the acquisition of Dren Bio (posted on December 18 2025).
Sanofi has acquired Vicebio (posted on December 11 2025).
Sanofi has acquired Vigil Neuroscience (posted on August 6 2025).
Blueprint Medicines and Sanofi have merged (posted on July 21 2025)..
Sanofi has announced the acquisition of Blueprint Medicines (posted on June 2 2025).
Sanofi has announced the acquisition of Vigil Neuroscience (posted on May 29 2025).
See more news about Sanofi Hide news involving Sanofi

Executives

View the org chart displaying its 26 main executives

Most searched biographies at Euroapi

Popular executive movements at Euroapi

Maria Rita Maresca, Site Director and Country General Manager, Hungary, has left the company (posted on February 6 2026).
Tristan Imbert will join the company as Independent Director on Dec. 31, 2025 (posted on December 11 2025).
Rodolfo Savitzky, Independent Member of the Supervisory Board, will retire on Dec. 31, 2025 (posted on October 1 2025).

Popular executive movements at Sanofi

Houman Ashrafian, Executive Vice President, Head of Research and Development, will leave the company on Sep. 1, 2026 (posted on June 23 2026).
Paulo Fontoura will join the company as Executive Vice President and Head of Research and Development on Sep. 1, 2026 (posted on June 23 2026).
Christel Heydemann has joined the company as Director (posted on May 7 2026).

Click here to view some more movements at Sanofi

Create your alert
to follow the executive moves at Euroapi.